首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

注射筆市場規模、佔有率和成長分析（按類型、治療方法、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1900455

注射筆市場規模、佔有率和成長分析（按類型、治療方法、最終用戶和地區分類）—2026-2033年產業預測

Injection Pen Market Size, Share, and Growth Analysis, By Type (Disposable Injection Pens, Reusable Injection Pens), By Therapy (Diabetes, Growth Hormone Therapy), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，注射筆市場規模將達到 524.2 億美元，到 2025 年將達到 565.8 億美元，到 2033 年將達到 1041.8 億美元，預測期（2026-2033 年）的複合年成長率為 7.93%。

全球注射筆市場受到糖尿病、癌症等慢性病盛行率上升以及人口老化的顯著影響。推動市場成長的關鍵因素包括人們對自行注射裝置的認知度不斷提高以及慢性病發病率的上升。糖尿病患者正迅速採用配備先進技術的可重複使用注射筆，尤其是那些透過藍牙連接計算碳水化合物攝取量和胰島素劑量的創新產品。此外，醫療專業人員也越來越傾向於使用自動注射筆，因為它們能夠實現精準、安全、便利的給藥。由於人口老化帶來的慢性病風險增加，注射筆的需求不僅在已開發國家，而且在發展中地區也在成長。

注射筆市場按類型、治療方法、最終用戶和地區進行細分。依類型分類，注射筆分為一次性注射筆和可重複使用注射筆。治療方法，注射筆可分為糖尿病治療、生長激素荷爾蒙療法、骨質疏鬆症治療、不孕症治療、肥胖症治療和其他治療方法。依最終使用者分類，注射筆可分為居家醫療機構和醫院/診所。依地區分類，注射筆可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

注射筆市場成長要素

糖尿病、肥胖症和荷爾蒙失衡等疾病的日益普遍，顯著推動了全球對注射筆的需求。隨著越來越多的患者需要持續治療，對易於使用、精準高效的自我注射裝置的需求也日益成長。這些工具不僅有助於慢性病的管理，也能鼓勵患者堅持處方治療，最終改善健康。因此，由於日益注重健康的消費者對創新給藥解決方案的需求，注射筆市場正經歷顯著成長。

制約注射筆市場的因素

口服藥物和輸液幫浦等替代給藥方式的日益普及，對注射筆市場構成了重大挑戰。隨著患者和看護者優先考慮這些替代方式的便利性，注射筆的需求可能會下降，從而導致供應問題。這種偏好的轉變可能會抑制注射筆類別的成長，因為注射筆難以與其他給藥系統提供的便利性和易用性競爭。因此，隨著消費者越來越不願意選擇傳統的注射方式，注射筆市場可能會陷入停滯。

注射筆市場趨勢

注射筆市場正呈現出顯著的智慧型注射筆普及趨勢，這類注射筆融合了先進技術，旨在提升患者照護。這些設備具備藍牙連接和行動應用程式相容性，可為使用者提供即時用藥監測，從而提高用藥依從性，並促進患者與醫護人員之間的溝通。這些智慧功能的整合不僅使患者能夠更有效地管理治療，也使醫護人員能夠根據精準數據追蹤和調整治療方案，最終提升注射筆市場的患者管理標準和治療效果。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Novo Nordisk A/S（Denmark）
Eli Lilly And Company（US）
Sanofi（France）
Ypsomed Holding AG（Switzerland）
Becton, Dickinson and Company（US）
Merck KGaA（Germany）
AstraZeneca（UK）
Owen Mumford（UK）
Sun Pharmaceutical Industries Ltd（India）
Pfizer Inc.（US）
Biocon（India）
Lupin（India）
Wockhardt Ltd.（India）
Medtronic（US）
Gerresheimer AG（Germany）
Shaily Engineering Plastics Ltd.（India）
SHL Medical AG（Switzerland）
Emperra GmbH E-Health Technologies（Germany）
Nemera France SAS（France）
Jiangsu Delfu Medical Device Co., Ltd.（China）
Solteam Medical（China）
Stevanato Group（Italy）
Wanhai Medical Instruments Co., Ltd.（China）

簡介目錄

Product Code: SQMIG35A2646

Injection Pen Market size was valued at USD 52.42 Billion in 2024 and is poised to grow from USD 56.58 Billion in 2025 to USD 104.18 Billion by 2033, growing at a CAGR of 7.93% during the forecast period (2026-2033).

The global injection pen market is significantly influenced by the rising prevalence of chronic illnesses such as diabetes and cancer, coupled with an aging population. Key factors driving market growth include heightened awareness of self-injectable devices and the increasing incidence of chronic diseases. Notably, the use of reusable injectable pens featuring advanced technology is surging among diabetic patients, as seen with innovative products that calculate carbohydrate intake and insulin dosage through Bluetooth connectivity. Additionally, automated injection pens are gaining favor among healthcare providers for their ability to deliver medications with precision, safety, and convenience. The demand for injection pens is escalating not only in developed nations but also in developing regions, propelled by the vulnerability of the aging population to chronic health issues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Injection Pen market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Injection Pen Market Segments Analysis

Injection Pen Market is segmented by Type, Therapy, End User, and region. Based on Type, the market is segmented into Disposable Injection Pens, and Reusable Injection Pens. Based on Therapy, the market is segmented into Diabetes, Growth Hormone Therapy, Osteoporosis, Fertility, Obesity, and Other Therapies. Based on End User, the market is segmented into Home Care Settings, Hospitals & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Injection Pen Market

The growing prevalence of conditions such as diabetes, obesity, and hormonal imbalances is significantly boosting the global demand for injection pens. With more patients requiring ongoing treatment, there is an escalating need for user-friendly, precise, and efficient self-administration devices. These tools not only facilitate easier management of chronic diseases but also enhance patient adherence to prescribed therapies, ultimately leading to better health outcomes. As a result, the market for injection pens is experiencing substantial growth, driven by the necessity for innovative delivery solutions that meet the demands of an increasingly health-conscious population.

Restraints in the Injection Pen Market

The increasing availability of alternative drug delivery methods, such as oral medications and infusion pumps, poses a significant challenge to the injection pen market. As patients and caregivers prioritize the convenience and ease of these alternatives, the demand for injection pens may decline, leading to potential supply issues. This shift in preference could hinder the growth of the injection pen sector, as stakeholders might find it difficult to compete with the simplicity and user-friendliness offered by other delivery systems. Consequently, the injection pen market may experience stagnation due to a growing reluctance among consumers to choose traditional injection methods.

Market Trends of the Injection Pen Market

The Injection Pen market is witnessing a significant trend toward the rising adoption of smart injection pens, which incorporate advanced technology to enhance patient care. These devices, featuring Bluetooth connectivity and compatibility with mobile applications, provide users with real-time monitoring of medication usage, which improves adherence and fosters better communication between patients and healthcare providers. This integration of smart features not only empowers patients to manage their treatment more effectively but also allows healthcare professionals to track and adjust therapies based on precise data, ultimately elevating the standards of patient management and health outcomes in the injection pen market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Supply Chain Analysis
Trade Analysis
Value Chain Analysis
Regulatory Landscape
Patent Analysis
Pricing Analysis
Customer & Buying Criteria Analysis
Case Study Analysis

Injection Pen Market by Type

Market Overview
Disposable Injection Pens
Reusable Injection Pens

Injection Pen Market by Therapy

Market Overview
Diabetes
- Insulin
- Glucagon-Like Peptide-1
Growth Hormone Therapy
Osteoporosis
Fertility
Obesity
Other Therapies

Injection Pen Market by End User

Market Overview
Home Care Settings
Hospitals & Clinics

Injection Pen Market Size by Region

Market Overview
North America
- US
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly And Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocon (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lupin (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wockhardt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shaily Engineering Plastics Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SHL Medical AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emperra GmbH E-Health Technologies (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemera France SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangsu Delfu Medical Device Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solteam Medical (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stevanato Group (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wanhai Medical Instruments Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments